Literature DB >> 1204209

Individual variation in inosine triphosphate accumulation in human erythrocytes.

J H Fraser, H Meyers, J F Henderson, L W Brox, E E McCoy.   

Abstract

Erythrocytes from 5% of a normal population accumulated relatively high amounts of radioactive inosine triphosphate (i.e., greater than 70 nmoles/10(10) cells in 2 hr) when they were incubated with [14C]hypoxanthine. The incidence of this characteristic in a mentally retarded population was 16%. Inosine triphosphate was synthesized from [14C]hypoxanthine, but not from [14C]adenine or [14C]guanine. The metabolism of [14C]adenine and [14C]guanine was the same in erythrocytes that accumulated "normal" and "high" amounts of inosine triphosphate. Inosine triphosphate did not accumulate in leukocytes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1204209     DOI: 10.1016/s0009-9120(75)93685-1

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  10 in total

1.  ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

Authors:  Jacques Fellay; Alexander J Thompson; Dongliang Ge; Curtis E Gumbs; Thomas J Urban; Kevin V Shianna; Latasha D Little; Ping Qiu; Arthur H Bertelsen; Mark Watson; Amelia Warner; Andrew J Muir; Clifford Brass; Janice Albrecht; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2010-02-21       Impact factor: 49.962

2.  Several factors including ITPA polymorphism influence ribavirin-induced anemia in chronic hepatitis C.

Authors:  Akihito Tsubota; Noritomo Shimada; Hiroshi Abe; Kai Yoshizawa; Rie Agata; Yoko Yumoto; Makiko Ika; Yoshihisa Namiki; Keisuke Nagatsuma; Hiroshi Matsudaira; Kiyotaka Fujise; Norio Tada; Yoshio Aizawa
Journal:  World J Gastroenterol       Date:  2012-11-07       Impact factor: 5.742

3.  Individual variation of nucleoside triphosphate pyrophosphohydrolase activity in human erythrocytes, granulocytes, lymphocytes, and platelets.

Authors:  V L Verhoef; S A Fuller; A J Morris
Journal:  Biochem Genet       Date:  1980-04       Impact factor: 1.890

4.  Purine salvage and metabolism in Babesia bovis.

Authors:  C Matias; S E Nott; A S Bagnara; W J O'Sullivan; A M Gero
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

5.  Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C.

Authors:  Mina Nakagawa; Naoya Sakamoto; Takako Watanabe; Yuki Nishimura-Sakurai; Izumi Onozuka; Seishin Azuma; Sei Kakinuma; Sayuri Nitta; Kei Kiyohashi; Akiko Kusano-Kitazume; Miyako Murakawa; Kohei Yoshino; Yasuhiro Itsui; Yasuhito Tanaka; Masashi Mizokami; Mamoru Watanabe
Journal:  Hepatol Int       Date:  2012-03-21       Impact factor: 6.047

6.  Erythrocyte inosine triphosphatase activity is decreased in HIV-seropositive individuals.

Authors:  Jörgen Bierau; Jaap A Bakker; Jolanda A Schippers; Janine A C Grashorn; Martijn Lindhout; Selwyn H Lowe; Aimée D C Paulussen; Annelies Verbon
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

7.  Inosine triphosphatase allele frequency and association with ribavirin-induced anaemia in Brazilian patients receiving antiviral therapy for chronic hepatitis C.

Authors:  Nathália Delvaux; Vanessa Duarte da Costa; Maristella Matos da Costa; Livia Melo Villar; Henrique Sérgio Moraes Coelho; Eliane Bordalo Cathalá Esberard; Priscila Pollo Flores; Carlos Eduardo Brandão-Mello; Cristiane Alves Villela-Nogueira; Adilson José de Almeida; Elisabeth Lampe
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-07-07       Impact factor: 2.743

8.  Measuring deaminated nucleotide surveillance enzyme ITPA activity with an ATP-releasing nucleotide chimera.

Authors:  Debin Ji; Elena I Stepchenkova; Jian Cui; Miriam R Menezes; Youri I Pavlov; Eric T Kool
Journal:  Nucleic Acids Res       Date:  2017-11-16       Impact factor: 16.971

Review 9.  Inosine Triphosphate Pyrophosphatase (ITPase): Functions, Mutations, Polymorphisms and Its Impact on Cancer Therapies.

Authors:  Mazin A Zamzami
Journal:  Cells       Date:  2022-01-24       Impact factor: 6.600

10.  Association between IPTA gene polymorphisms and hematological abnormalities in hepatitis C virus-infected patients receiving combination therapy.

Authors:  Jow Jyh Hwang; Ching Chu Lo; Chien Hung Lin; Hsu Sheng Cheng; I Wen Hung; Wan Ju Tsai; Chien Hui Hung
Journal:  Gut Liver       Date:  2015-03       Impact factor: 4.519

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.